Menu

Report Library

All Reports
Datapack – Pharmaprojects Pharma R&D Annual Review 2016

December 02, 2016

Stay informed on industry R&D trends and perform your own in-depth analysis. This datapack presents the supporting data from our seminal white paper, Pharmaprojects Pharma R&D Annual Review 2016. Over the past 25 years, the pharma R&D sector has seen many twists and turns. Included with your purchase, our white paper looks at developments in a year that saw some new players make the big time, while others hit skid row after one too many negative (clinical) reviews. Sourced from Pharmaprojects, the industry's most trusted clinical drug development database, the information included in this datapack covers multiple views of the R&D pipeline by company, development phase, therapy area, and more, allowing you to perform your own analysis and dive deeper into the underlying data.
Disease Group Covered: Allergy
Autoimmune/immunology
Cardiovascular
Dermatology
Endocrine
ENT/Dental
Gastroenterology (Non Inflammatory Bowel Disease)
Hematology
Infectious Disease
Metabolic
Neurology
Not Specified
Obstetrics/Gynecology
Oncology
Ophthalmology
Orthopedics
Psychiatry
Renal
Respiratory
Rheumatology (Non Autoimmune)
Urology